INEGY 10 MG20 MG TABLETS

מדינה: ישראל

שפה: אנגלית

מקור: Ministry of Health

מרכיב פעיל:

EZETIMIBE; SIMVASTATIN

זמין מ:

MERCK SHARP & DOHME ISRAEL LTD

קוד ATC:

C10AA01

טופס פרצבטיות:

TABLETS

הרכב:

SIMVASTATIN 20 MG; EZETIMIBE 10 MG

מסלול נתינה (של תרופות):

PER OS

סוג מרשם:

Required

תוצרת:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

קבוצה תרפויטית:

SIMVASTATIN

איזור תרפויטי:

SIMVASTATIN

סממני תרפויטית:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

תאריך אישור:

2012-04-30